Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Denis Chem LabBOM:537536 +1.79%74 PS Ratio is 0.53 as of Aug. 06, 2026, which is 32% below its 10-year median of 0.78. GuruFocus rates BOM:537536 with a GF Score™ of 74/100 and a GF Value™ of ₹118.81 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 953 Drug Manufacturers companies, Denis Chem Lab ranks better than 86.25% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Denis Chem Lab's share price is ₹69.87.
Denis Chem Lab's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹131.16. Hence, Denis Chem Lab's PS Ratio for today is 0.53.
The historical rank and industry rank for Denis Chem Lab's PS Ratio or its related term are showing as below:
BOM:537536'
s PS Ratio Range Over the Past 10 Years
Min: 0.22 Med: 0.78 Max: 1.71
Current: 0.54
During the past 13 years, Denis Chem Lab's highest PS Ratio was 1.71. The lowest was 0.22. And the median was 0.78.
BOM:537536's PS Ratio is ranked better than 86.25% of 953
companies
in the Drug Manufacturers industry
Industry Median: 2.32
vs BOM:537536: 0.54
Denis Chem Lab Ltd revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Denis Chem Lab was 4.90% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 4.20% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 9.90% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 3.50% per year.
During the past 13 years, Denis Chem Lab's highest 3-Year average Revenue per Share Growth Rate was 15.40% per year. The lowest was -33.30% per year. And the median was 1.70% per year.
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Denis Chem Lab PS Ratio Related Terms
Denis Chem Lab PS Ratio Historical Data
* Premium members only.
The historical data trend for Denis Chem Lab's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Denis Chem Lab's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Denis Chem Lab PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Denis Chem Lab's PS Ratio distribution charts can be found below:
* The bar in red indicates where Denis Chem Lab's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Denis Chem Lab's Share Price of today is ₹69.87. Denis Chem Lab's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹131.16.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Denis Chem Lab (BOM:537536) has a PS Ratio of 0.53 as of Aug. 06, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Denis Chem Lab and its competitors. This is 32% below median its historical median of 0.78. Over the past decade, Denis Chem Lab's PS Ratio has ranged from 0.22 to 1.71. According to the industry distribution chart, Denis Chem Lab ranks #131 out of 953 companies in the Drug Manufacturers industry, placing it in the top 13.7%.
Is Denis Chem Lab's PS Ratio too high?
Denis Chem Lab's current PS Ratio of 0.53 is 32% below median its 10-year median of 0.78. Over the past 10 years, this metric has ranged from a low of 0.22 to a high of 1.71. The Drug Manufacturers industry median PS Ratio is 2.32. Denis Chem Lab's value of 0.53 is 77.2% below this industry median. Based on the distribution chart, Denis Chem Lab ranks #131 out of 953 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Denis Chem Lab has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Denis Chem Lab's PS Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Denis Chem Lab ranks #131 out of 953 companies for PS Ratio. This places Denis Chem Lab in the top 14% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.32. Denis Chem Lab's value of 0.53 is 77.2% below this benchmark. Historically, Denis Chem Lab's own PS Ratio has ranged from 0.22 to 1.71 over the past decade. While the company's 10-year median is 0.78 vs. the industry median of 2.32, Denis Chem Lab has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.32, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Denis Chem Lab's current PS Ratio of 0.53 is 77.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Denis Chem Lab and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Denis Chem Lab's current PS Ratio is 0.53, which is 32% below median its own 10-year median of 0.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Denis Chem Lab stock overvalued right now?
Based on GuruFocus' analysis, Denis Chem Lab (BOM:537536) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹118.81, compared to a current price of ₹69.87 — trading 41.2% below its estimated fair value. The current PS Ratio is 0.53, which is 32% below median its 10-year median of 0.78 and 77.2% below the Drug Manufacturers industry median of 2.32. Denis Chem Lab's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Denis Chem Lab (BOM:537536), the current PS Ratio is 0.53 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Denis Chem Lab (BOM:537536) Overvalued in 2026?
Based on GuruFocus' analysis, Denis Chem Lab stock appears to be undervalued.
The current stock price of ₹69.87 is trading 41.2% below its estimated GF Value™ of ₹118.81.
GuruFocus considers Denis Chem Lab to be Significantly Undervalued.
Key valuation signals for BOM:537536:
PS Ratio: 0.53 (32% below median its 10-year median of 0.78)
GF Value™: ₹118.81 vs. price of ₹69.87 (41.2% below fair value)
Industry Position: 77.2% below the Drug Manufacturers median (#131 of 953)
No single metric tells the full story. See the BOM:537536 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Denis Chem Lab Ltd is a pharmaceutical company involved in the manufacturing of pharmaceutical products. The company offers sterile intravenous injectables for human and veterinary use for different therapeutic areas. Its product portfolio includes antibiotic injections, diuretic injections, parenteral amino acid injections, plasma volume expanders, anti-pyretic Inj. irrigation solutions and dialysis solutions. The company has only one reportable segment which is Manufacturing, and Sales of Transfusion Solution in Bottles It generates its revenues through the sale of transfusion solution in bottles.
74GF Score
Get the complete analysis for BOM:537536
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:537536 has been successfully added to your 
